Insider Transactions in Q4 2022 at Predictive Oncology Inc. (POAI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
6,000
+4.74%
|
$0
$0.41 P/Share
|
|
Dec 02
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+2.85%
|
$0
$0.52 P/Share
|
|
Dec 02
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
8,795
+10.99%
|
$0
$0.57 P/Share
|
|
Dec 01
2022
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,762
+50.0%
|
-
|
|
Nov 29
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.03%
|
$0
$0.36 P/Share
|
|
Nov 01
2022
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
213,300
+33.86%
|
-
|
|
Oct 25
2022
|
David Stewart Smith |
BUY
Grant, award, or other acquisition
|
Direct |
18,911
+50.0%
|
-
|
|
Oct 03
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,667
+17.47%
|
-
|
|
Oct 03
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+16.11%
|
-
|
|
Oct 03
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+6.14%
|
-
|
|
Oct 03
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+18.13%
|
-
|
|
Oct 03
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+14.92%
|
-
|